Naples, Italy

Luca Sanguigno

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Ann & Robert H. Lurie Children's Hosp. of Chicago, Ann & Robert H. Lurie Children's Hospital, Ann & Robert H. Lurie Children's Hospital of Chicago. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luca Sanguigno. Retrieved from https://idiyas.com/inventor/luca-sanguigno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Luca Sanguigno

Introduction

Luca Sanguigno is an accomplished inventor based in Naples, Italy. He has made significant contributions to the field of medical research, particularly in the development of anti-Nodal antibodies. With a total of three patents to his name, Sanguigno's work has the potential to impact the diagnosis and treatment of Nodal-related disorders.

Latest Patents

Sanguigno's latest patents include innovative methods related to anti-Nodal antibodies. The first patent focuses on the use of these antibodies for diagnosing, preventing, and treating Nodal-related disorders or diseases. This groundbreaking work aims to provide new avenues for medical intervention and improve patient outcomes.

Career Highlights

Throughout his career, Sanguigno has worked with prestigious institutions, including the Ann & Robert H. Lurie Children's Hospital of Chicago. His experience in such a renowned environment has allowed him to refine his research skills and contribute to significant advancements in pediatric medicine.

Collaborations

Sanguigno has collaborated with notable professionals in his field, including Menotti Ruvo and Annamaria Sandomenico. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Luca Sanguigno's innovative work in the field of anti-Nodal antibodies showcases his dedication to advancing medical science. His contributions have the potential to change the landscape of treatment for Nodal-related disorders, highlighting the importance of continued research and collaboration in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…